Remarkable response to rituximab in a patient with atypical CD20++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia
Rituximab, a chimeric monoclonal antibody which binds to the CD20 antigen, has been reported in several studies to induce remissions in low- and high-grade non-Hodgkin’s lymphoma without causing myelosuppression. We report here a case of a 68-year-old female patient with an atypical mantle cell lymp...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
[2004]
|
| In: |
Annals of hematology
Year: 2004, Volume: 83, Issue: 5, Pages: 316-318 |
| ISSN: | 1432-0584 |
| DOI: | 10.1007/s00277-003-0793-z |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00277-003-0793-z
|
| Author Notes: | R. Seggewiss, A.D. Ho, A. Kraemer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1780212739 | ||
| 003 | DE-627 | ||
| 005 | 20240415193239.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211203s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00277-003-0793-z |2 doi | |
| 035 | |a (DE-627)1780212739 | ||
| 035 | |a (DE-599)KXP1780212739 | ||
| 035 | |a (OCoLC)1341434603 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Seggewiß-Bernhardt, Ruth |d 1972- |e VerfasserIn |0 (DE-588)123726441 |0 (DE-627)082730881 |0 (DE-576)293847037 |4 aut | |
| 245 | 1 | 0 | |a Remarkable response to rituximab in a patient with atypical CD20++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia |c R. Seggewiss, A.D. Ho, A. Kraemer |
| 246 | 3 | 3 | |a Remarkable response to rituximab in a patient with atypical CD20 ++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia |
| 264 | 1 | |c [2004] | |
| 300 | |b Illustrationen | ||
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 13 November 2003 | ||
| 500 | |a Die Pluszeichen im Titel sind hochgestellt | ||
| 500 | |a Gesehen am 03.12.2021 | ||
| 520 | |a Rituximab, a chimeric monoclonal antibody which binds to the CD20 antigen, has been reported in several studies to induce remissions in low- and high-grade non-Hodgkin’s lymphoma without causing myelosuppression. We report here a case of a 68-year-old female patient with an atypical mantle cell lymphoma infiltrating only the bone marrow without leukemic involvement or any other nodal or extranodal manifestations. Progressive severe pancytopenia due to the diffuse bone marrow infiltration led to life-threatening infections following oral chlorambucil treatment. No response to chlorambucil was noted. The patient attained a complete remission after salvage therapy with four weekly infusions of single-agent rituximab at a standard dose of 375 mg/m2. Thus, anti-CD20 antibody may be the treatment of choice for patients with CD20+ B-non-Hodgkin’s lymphoma who cannot tolerate chemotherapy due to high risk of infectious complications as a result of severe pancytopenia. | ||
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Krämer, Alwin |e VerfasserIn |0 (DE-588)1067780025 |0 (DE-627)819183431 |0 (DE-576)426900820 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d Berlin : Springer, 1991 |g 83(2004), 5, Seite 316-318 |h Online-Ressource |w (DE-627)253389852 |w (DE-600)1458429-3 |w (DE-576)072283157 |x 1432-0584 |7 nnas |a Remarkable response to rituximab in a patient with atypical CD20++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia |
| 773 | 1 | 8 | |g volume:83 |g year:2004 |g number:5 |g pages:316-318 |g extent:3 |a Remarkable response to rituximab in a patient with atypical CD20++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00277-003-0793-z |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211203 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 1067780025 |a Krämer, Alwin |m 1067780025:Krämer, Alwin |p 3 |y j | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN1780212739 |e 4013540266 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title_sort":"Remarkable response to rituximab in a patient with atypical CD20++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia","title":"Remarkable response to rituximab in a patient with atypical CD20++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"disp":"Remarkable response to rituximab in a patient with atypical CD20++ mantle cell lymphoma of the bone marrow leading to severe pancytopeniaAnnals of hematology","id":{"eki":["253389852"],"issn":["1432-0584"],"zdb":["1458429-3"]},"note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"recId":"253389852","origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedKey":"1991","publisher":"Springer","dateIssuedDisp":"1991-"}],"titleAlt":[{"title":"Hematology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie","title":"Annals of hematology","title_sort":"Annals of hematology"}],"part":{"text":"83(2004), 5, Seite 316-318","year":"2004","volume":"83","issue":"5","pages":"316-318","extent":"3"},"language":["eng"],"pubHistory":["62, 1 (Februrary 1991)-"]}],"note":["Published online: 13 November 2003","Die Pluszeichen im Titel sind hochgestellt","Gesehen am 03.12.2021"],"physDesc":[{"extent":"3 S.","noteIll":"Illustrationen"}],"id":{"eki":["1780212739"],"doi":["10.1007/s00277-003-0793-z"]},"titleAlt":[{"title":"Remarkable response to rituximab in a patient with atypical CD20 ++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1780212739","origin":[{"dateIssuedDisp":"[2004]","dateIssuedKey":"2004"}],"person":[{"display":"Seggewiß-Bernhardt, Ruth","given":"Ruth","role":"aut","family":"Seggewiß-Bernhardt"},{"given":"Anthony Dick","role":"aut","display":"Ho, Anthony Dick","family":"Ho"},{"display":"Krämer, Alwin","role":"aut","given":"Alwin","family":"Krämer"}],"name":{"displayForm":["R. Seggewiss, A.D. Ho, A. Kraemer"]}} | ||
| SRT | |a SEGGEWISSBREMARKABLE2004 | ||